成纤维细胞生长因子23与心力衰竭：情况愈发复杂。
Fibroblast growth factor 23 and heart failure: the plot thickens.
作者信息
Gutiérrez Orlando M
机构信息
Departments of Medicine and Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.
出版信息
Nephrol Dial Transplant. 2016 May;31(5):688-90. doi: 10.1093/ndt/gfv401. Epub 2015 Nov 27.
Abstract
…The findings of Andersen and colleagues provide new incentive to further elucidate the full spectrum of ways that excess FGF23 impacts cardiac function and how this may ultimately contribute to the pathophysiology of heart failure in CKD…
摘要
安徒生及其同事的研究结果为进一步阐明过量成纤维细胞生长因子23（FGF23）影响心脏功能的所有方式以及这最终如何导致慢性肾脏病（CKD）心力衰竭的病理生理学提供了新的动力。
相似文献
1
Fibroblast growth factor 23 and heart failure: the plot thickens.成纤维细胞生长因子23与心力衰竭：情况愈发复杂。
Nephrol Dial Transplant. 2016 May;31(5):688-90. doi: 10.1093/ndt/gfv401. Epub 2015 Nov 27.
2
Erythropoietin and outcome prediction in patients with heart failure: the plot thickens..红细胞生成素与心力衰竭患者的预后预测：情况愈发复杂。
Eur Heart J. 2008 Jun;29(12):1481-2. doi: 10.1093/eurheartj/ehn229. Epub 2008 May 25.
3
The plot thickens: hemoconcentration, renal function, and survival in heart failure.情况愈发复杂：心力衰竭中的血液浓缩、肾功能与生存情况。
Circulation. 2010 Jul 20;122(3):233-5. doi: 10.1161/CIRCULATIONAHA.110.965293. Epub 2010 Jul 6.
4
Exogenous ketones in the healthy heart: the plot thickens.健康心脏中的外源性酮体：情况愈发复杂。
Cardiovasc Res. 2021 Mar 21;117(4):995-996. doi: 10.1093/cvr/cvaa283.
5
Head to head comparison of intact and C-terminal fibroblast growth factor 23 in heart failure patients with reduced ejection fraction.射血分数降低的心力衰竭患者中完整型和成纤维细胞生长因子23 C末端的头对头比较。
Int J Cardiol. 2017 Dec 1;248:270-273. doi: 10.1016/j.ijcard.2017.06.129. Epub 2017 Jul 5.
6
Reply to 'Use of serum fibroblast growth factor 23 vs. plasma B-type natriuretic peptide levels in assessing the pathophysiology of patients with heart failure'.对“血清成纤维细胞生长因子23与血浆B型利钠肽水平在评估心力衰竭患者病理生理学中的应用”的回复
Hypertens Res. 2017 Oct 5;40(10):900-901. doi: 10.1038/hr.2017.59. Epub 2017 Apr 27.
7
Fibroblast growth factor 23 and the quest for the Holy Grail in heart failure: will the Crusaders be forced to surrender?成纤维细胞生长因子23与心力衰竭领域的圣杯探寻：“十字军”会被迫放弃吗？
Eur J Heart Fail. 2020 Apr;22(4):710-712. doi: 10.1002/ejhf.1786. Epub 2020 Mar 4.
8
Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients.成纤维细胞生长因子23、可溶性ST2和半乳糖凝集素-3对心力衰竭患者心血管死亡预后的比较
Int J Cardiol. 2015 Jun 15;189:185-7. doi: 10.1016/j.ijcard.2015.04.074. Epub 2015 Apr 11.
9
The growing problem of obesity and the heart: the plot "thickens".肥胖与心脏问题日益严重：情况愈发复杂。
J Am Coll Cardiol. 2006 Feb 7;47(3):617-9. doi: 10.1016/j.jacc.2005.11.014. Epub 2006 Jan 18.
10
Neutrophil gelatinase-associated lipocalin and worsening renal function in acute heart failure: the plot thickens.中性粒细胞明胶酶相关脂质运载蛋白与急性心力衰竭患者肾功能恶化：情况愈发复杂。
J Cardiovasc Med (Hagerstown). 2013 Sep;14(9):635-6. doi: 10.2459/JCM.0b013e32836382cd.
引用本文的文献
1
A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies.心血管疾病管理的综合述评：心脏生物标志物、成像方式、药物治疗、手术干预和草药疗法。
Cells. 2024 Sep 1;13(17):1471. doi: 10.3390/cells13171471.
2
FGF23 modulates the effects of erythropoietin on gene expression in renal epithelial cells.成纤维细胞生长因子23调节促红细胞生成素对肾上皮细胞基因表达的影响。
Int J Nephrol Renovasc Dis. 2018 Apr 4;11:125-136. doi: 10.2147/IJNRD.S158422. eCollection 2018.
本文引用的文献
1
Elevation of circulating but not myocardial FGF23 in human acute decompensated heart failure.循环而非心肌中的 FGF23 在人类急性失代偿性心力衰竭中的升高。
Nephrol Dial Transplant. 2016 May;31(5):767-72. doi: 10.1093/ndt/gfv398. Epub 2015 Dec 13.
2
Association of Fibroblast Growth Factor-23 Levels and Angiotensin-Converting Enzyme Inhibition in Chronic Systolic Heart Failure.成纤维细胞生长因子 23 水平与血管紧张素转换酶抑制剂在慢性收缩性心力衰竭中的相关性。
JACC Heart Fail. 2015 Oct;3(10):829-39. doi: 10.1016/j.jchf.2015.05.012.
3
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy.心脏成纤维细胞生长因子受体4的激活导致左心室肥厚。
Cell Metab. 2015 Dec 1;22(6):1020-32. doi: 10.1016/j.cmet.2015.09.002. Epub 2015 Oct 1.
4
Comparison of fibroblast growth factor 23, soluble ST2 and Galectin-3 for prognostication of cardiovascular death in heart failure patients.成纤维细胞生长因子23、可溶性ST2和半乳糖凝集素-3对心力衰竭患者心血管死亡预后的比较
Int J Cardiol. 2015 Jun 15;189:185-7. doi: 10.1016/j.ijcard.2015.04.074. Epub 2015 Apr 11.
5
Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23.实验性心肌梗死上调循环中的成纤维细胞生长因子-23。
J Bone Miner Res. 2015 Oct;30(10):1831-9. doi: 10.1002/jbmr.2527. Epub 2015 May 6.
6
Fibroblast growth factor 23 and risk of incident stroke in community-living adults.成纤维细胞生长因子23与社区居住成年人发生中风的风险
Stroke. 2015 Feb;46(2):322-8. doi: 10.1161/STROKEAHA.114.007489. Epub 2015 Jan 6.
7
FGF23 is associated with disease severity and prognosis in chronic heart failure.成纤维细胞生长因子23（FGF23）与慢性心力衰竭的疾病严重程度及预后相关。
Eur J Clin Invest. 2014 Dec;44(12):1150-8. doi: 10.1111/eci.12349. Epub 2014 Nov 3.
8
Pathophysiological impact of serum fibroblast growth factor 23 in patients with nonischemic cardiac disease and early chronic kidney disease.血清成纤维细胞生长因子23对非缺血性心脏病合并早期慢性肾脏病患者的病理生理影响
Am J Physiol Heart Circ Physiol. 2014 Nov 15;307(10):H1504-11. doi: 10.1152/ajpheart.00331.2014. Epub 2014 Sep 12.
9
FGF-23 dysregulates calcium homeostasis and electrophysiological properties in HL-1 atrial cells.成纤维细胞生长因子23（FGF-23）会破坏HL-1心房细胞中的钙稳态和电生理特性。
Eur J Clin Invest. 2014 Aug;44(8):795-801. doi: 10.1111/eci.12296.
10
Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study.成纤维细胞生长因子-23与冠心病、心力衰竭及心血管疾病死亡率的发生：社区动脉粥样硬化风险研究
J Am Heart Assoc. 2014 Jun 10;3(3):e000936. doi: 10.1161/JAHA.114.000936.
Zotero 插件